The progression from obesity to diabetes is linked to FTO’s dual influence on energy balance and adipose tissue, where its regulatory effects can contribute to systemic metabolic dysfunctions, such as insulin resistance, that characterize diabetes. This evidence concerns the gene FTO and obesity due to melanocortin 4 receptor deficiency.